ArticleFrontiers in microbiology2025
Optimal Effective Concentration Combinations and synergy evaluations for binary antimicrobial combinations
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Zinc oxide-bacteriophage synergistic combination for dual-mode antibacterial activity against multidrug-resistant Escherichia coli.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Investigation of antimicrobial synergism of actinomycin derivatives fromTurkish journal of biology = Turk biyoloji dergisi · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study provides a comparative analysis of Optimal Effective Concentration Combinations (OPECCs) and synergy evaluations derived from the Loewe additivity and Bliss independence models for binary antimicrobial combinations Methods: Binary combinations of Benzalkonium chloride, Chlorhexidine, Cetylpyridinium chloride, and Ciprofloxacin were tested against Results: All OPECCs were determinable for each binary combination pair. For each binary concentration component, the OPECC lay below the respective minimum effective concentration in single application. The synergy scores obtained with both models ranged from -13.4 (antagonistic) to 11.2 (synergistic), with consistently higher scores for the Bliss model. However, the concentration pairs at maximum synergy, determined using the respective matrices, showed inconsistent antibacterial assessments. No pattern could be derived regarding the antibacterial effect of these concentrations in relation to the OPECCs, nor between the two synergy models. The general synergy score of a combination also does not inevitably reflect the results at effective concentrations. Conclusion: The comparison demonstrated that the assumptions like "additivity" or "independence" underlying these models can result in concentration pairs at maximum synergy that may not necessarily be effective. As a consequence, the synergy evaluation methods tested do not account for the effectiveness of the assessed concentration pairs. In contrast, the model-independent OPECC method identifies effective concentration combinations directly from experimental data, without reliance on interaction assumptions or further data processing. The separating curve is based on directly measured optical density (OD) values of the binary concentration combinations, thus representing the real situation. By offering an alternative or complementary approach to existing models, the OPECC method may support more accurate identification of effective antimicrobial combinations and provide valuable insights for the development of optimized treatment strategies in the context of rising antimicrobial resistance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.